Option chain shows key data for Burning Rock Biotech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Burning Rock Biotech.

Burning Rock Biotech (NASDAQ:BNR) Stock, Option Chain

Burning Rock Biotech

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEHR

AKAN

AMLI

CETX

CMND

CTCX

GLXG

GRTS

JTAI

KDLY

LILM

LKCO

LUXH

MLGO

MNTS

NIVF

TSLA

ZENA

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Asia

Penny Stocks

Health Care

General

Key Takeaways:


	Burning Rock announced its shares could be delisted due to prolonged trading below the required $1 threshold
	The cancer detection specialist’s former biggest revenue source tumbled 40.6% in the third quarter amid an industry crackdown, spotlighting a major risk for Chinese companies


By Doug Young

Sinking Burning Rock Faces De-Listing. But Could Privatization Bid Come First?

Biotech

Key Takeaways:


	New Horizon Health posted a 61.3 million yuan adjusted profit in the first half of 2023, benefiting from soaring revenue for its three approved products
	The company sees big growth potential for its home-based cervical cancer screening product


By Molly Wen

New Horizon Health Finds Formula For Profits Ahead Of Schedule

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech Ltd

Brenmiller Energy Ltd

Earnings

Press Releases

Burning Rock Reports First Quarter 2024 Financial Results

Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines

Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement

Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares

Burning Rock Reports Second Quarter 2024 Financial Results

Management

Burning Rock Announces Changes to Management and Board of Directors

NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China

Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024

Burning Rock Reports Third Quarter 2024 Financial Results

Burning Rock Announces Results of 2024 Annual General Meeting

Aadi Bioscience

Adicet Bio

Achilles Therapeutics plc - American Depositary Shares

Achilles Therapeutics

Agenus

Aligos Therapeutics

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Aerovate Therapeutics, Inc. - Common Stock

Aerovate Therapeutics

BeyondSpring

Cibus

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

IO Biotech

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Kronos Bio

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

OSR Holdings

PMV Pharma

Pyxis Oncology

Quince Therapeutics

Shattuck Labs

X4 Pharmaceuticals

Exagen

Comments

Burning Rock Biotech

Burning Rock Biotech (BNR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga